| ALL | acute lymphoblastic leukemia |
| 3D | three-dimensional |
| GLS 3D | left ventricle 3D global longitudinal strain |
| GCS 3D | left ventricle 3D global circumferential strain |
| GRS 3D | left ventricle 3D global radial strain |
| EFS | event-free survival |
| OS | overall survival |
| CTRCD | cancer therapy related cardiac dysfunction |
| CCM | chemotherapy-induced cardiomyopathy |
| 2D-STE | two-dimensional speckle-tracing echocardiography |
| 3D-STE | three-dimensional speckle-tracking echocardiography |
| LVEF 3D | left ventricle ejection fraction 3D |
| EDV 3D | end diastolic volume 3D |
| ESV 3D | end systolic volume 3D |
| ESVI 3D | end systolic volume indexed 3D |
| min | minimum |
| max | maximum |
| WBC | white blood cells |
| AIEOP BMF 2017 | international collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia |
| ALL IC-BMF 2009 | Randomized Trial of the I-BFM-SG for the Management of Childhood non-B Acute Lymphoblastic Leukemia |
| M1/2/3 | marrow, <5% blasts (M1); marrow ≥5 to <25% blasts (M2), marrow, ≥25% blasts (M3) |
| BSA | body surface area |
| BMI | body mass index |